IDEXX Laboratories, Inc. vs Boston Beer Company Inc — how do they compare? IDEXX Laboratories, Inc. trades at $563.81 (market cap $44.48B), while Boston Beer Company Inc trades at $170.75 (market cap $1.88B). The key difference: IDEXX Laboratories, Inc. is far larger — about 23.7× Boston Beer Company Inc's market cap. Which is the better fit depends on your goals.
| IDXX | SAM | |
|---|---|---|
Market Cap | $44.48B | $1.88B |
Sector | Health | Consumer Staples |
52-Week High | $766.68 | $260.05 |
52-Week Low | $520.87 | $161.08 |
Enterprise Value | $45.38B | $1.75B |
Trailing returns across standard periods
Latest headlines on both assets
Idexx Laboratories primarily develops, manufactures, and distributes diagnostic products, equipment, and services for pets and livestock. Its key product lines include single-use canine and feline test kits that veterinarians can employ in the office, benchtop chemistry and hematology analyzers for test-panel analysis on-site, reference lab services, and tests to detect and manage disease in livestock. The firm also offers vet practice management software and consulting services to animal hospitals. Idexx gets about 38% of its revenue from outside the United States.
Read more on IDXX →Boston Beer is a leader in U.S. high-end malt beverages and adjacent categories, with strong positions in craft beer, hard cider, and hard seltzer. The firm sells an array of flavor variants and package sizes, predominantly centered around four priority brands: Samuel Adams, Angry Orchard, Twisted Tea, and Truly Hard Seltzer. Its drinks are produced in both company-owned breweries as well as through third-party contract arrangements, and while the company primarily goes to market through independent wholesalers (as mandated by law), it operates a fairly large salesforce to induce demand across the value chain (distributors, retailers, and drinkers). The preponderance of revenue is generated domestically.
Read more on SAM →